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Abstract
Radiotherapy is commonly planned on the basis of physical dose received by 
the tumour and surrounding normal tissue, with margins added to address the 
possibility of geometric miss. However, recent experimental evidence suggests 
that intercellular signalling results in a given cell’s survival also depending on 
the dose received by neighbouring cells. A model of radiation-induced cell 
killing and signalling was used to analyse how this effect depends on dose and 
margin choices. Effective Uniform Doses were calculated for model tumours 
in both idealised cases with no delivery uncertainty and more realistic cases 
incorporating geometric uncertainty. In highly conformal irradiation, a lack 
of signalling from outside the target leads to reduced target cell killing, 
equivalent to under-dosing by up to 10% compared to large uniform fields. 
This effect is significantly reduced when higher doses per fraction are 
considered, both increasing the level of cell killing and reducing margin 
sensitivity. These effects may limit the achievable biological precision of 
techniques such as stereotactic radiotherapy even in the absence of geometric 
uncertainties, although it is predicted that larger fraction sizes reduce the 
relative contribution of cell signalling driven effects. These observations may 
contribute to understanding the efficacy of hypo-fractionated radiotherapy.
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1. Introduction
Although advances in radiotherapy delivery such as Intensity Modulated Radiotherapy 
(IMRT) and Volumetric Modulated Arc Therapy (VMAT) offer significant improvements in 
dose conformality, exposure of normal tissue remains a limiting factor in many cases.
One major challenge in this area is uncertainty in treatment set-up and delivery, where 
patient motion may lead to treatment fields no longer being aligned with target structures, 
an effect known as geometric miss. This can cause significant under- and over-dosing of 
tumour and organs at risk. To account for geometric miss in clinical scenarios, once the 
Clinical Target Volume (CTV) has been delineated, an additional margin is added to give 
the Planning Target Volume (PTV) (ICRU 1993). As this necessarily requires additional 
exposure of normal tissues, there is considerable interest in minimising geometric uncer-
tainties and determining margin recipes to accurately compensate for them (Van Herk et al 
2000, van Herk 2004, Herschtal et al 2013, Selvaraj et al 2013). Reductions in margins are 
not without risk, however, as under-dosing of tumours may significantly impact upon local 
control.
Even if geometric issues can be fully addressed, there may remain motivation for irradiat-
ing targets larger than the CTV. This is due to non-targeted radiobiological effects driven by 
intercellular signalling—commonly known as bystander effects (Prise and O’Sullivan 2009). 
While typically associated with low dose exposures, recent results have shown large contri-
butions from communication between cells exposed to high doses which remain in contact 
for extended periods (Suchowerska et al 2005, Mackonis et al 2007, Butterworth et al 2011, 
Butterworth et al 2010), with reports of bystander cell killing of more than 50% and saturation 
doses greater than 4 Gy. This has been further supported by evidence of significant out-of-field 
effects in in vivo systems (Mancuso et al 2008, Mancuso et al 2013).
Recent mathematical analysis has suggested that intercellular communication may play a 
significant role in cell death even in populations exposed to doses up to several Gray (Ebert et 
al 2010, Blyth and Sykes 2011, McMahon et al 2012, McMahon et al 2013a, Balderson and 
Kirkby 2014). This is potentially very important for radiotherapy planning, as any depend-
ence of in-target cell killing on out-of-field dose would conflict with the goal of minimis-
ing exposure of healthy tissue. A recent study (McMahon et al 2013b) investigated prostate 
radiotherapy plans incorporating intercellular signalling, finding small but consistent impacts 
on predicted tumour killing compared to plans considering physical dose alone (equivalent to 
approximately 5% target under-dosing).
However, that work did not investigate the impact of either fractionation schedule or 
margin prescription, both of which may significantly impact on the contribution of signal-
ling effects. These factors are particularly important in current radiotherapy practice, as 
Stereotactic Ablative Radiotherapy (SABR) has emerged as a treatment option for localised 
cancers, delivering treatments with large fraction sizes and extremely small margins of 3–5 
mm or less, with interest in further reductions through image guided radiotherapy techniques. 
These approaches have shown excellent clinical results, leading to considerable interest in 
their underlying biology (Sheu et al 2013, Brown et al 2014, Tree et al 2014), although there 
has been a large variation in dose fractionation regimes utilised in clinical studies.
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This work investigates the impact of margin and fractionation choice on tumour cell killing 
in light of intercellular signalling, both in an idealised scenario as well as one incorporating 
geometric uncertainties.
2. Methods
2.1. Treatment scenario and dose distributions
As in previous radiotherapy margin studies (Van Herk et al 2000, van Herk 2004, Selvaraj et 
al 2013), the irradiation of spherical CTVs was modelled. Dose deliveries are prescribed to a 
PTV, which is defined as the CTV plus a uniform margin. These volumes are embedded in a 
larger tissue volume, sized such that the PTV has a margin of at least 30 mm in all directions. 
For computational purposes, this volume is divided into 1 mm3 voxels.
Spherically symmetric conformal dose distributions were modelled, with radial dose dis-
tributions of = + − +D r( )
D
1 ea r r d
0
( ( 0 ))
, where D0 is the prescription dose, r is the distance from the 
centre of the CTV, and r0 is the total PTV radius. This gives a sigmoidal dose distribution 
centred on the target, with 50% dose delivered at a distance of d from the PTV edge. While 
idealised, these dose distributions are comparable to those which can be delivered clinically 
through techniques such as VMAT (Selvaraj et al 2013). An illustration of this dose distribu-
tion is shown in figure 1.
The distance d is set to 5 mm, and the steepness of the dose distribution (characterised by a) 
is set such that the edge of the PTV sees 95% of the prescription dose, which leads to an 80% 
to 20% penumbral width of 4.8 mm.
2.2. Intercellular signalling model
Survival incorporating intercellular signalling is investigated using previously published mod-
els (McMahon et al 2012, McMahon et al 2013a, 2013b), summarised briefly below.
Within each voxel, cells are exposed to a uniform dose. This causes direct damage (pro-
portional to dose) and induces the secretion of potentially damaging signals. These signals are 
produced by cells for a time proportional to the physical dose they receive and are assumed 
to be unstable, being depleted in a simple exponential decay with coefficient λ. In uniformly 
irradiated populations, this leads to a signal which builds towards an equilibrium concentra-
tion before decaying away as cells cease signalling.
Above a certain signal threshold, cells are assumed to suffer the induction of signalling-
induced damage at a constant rate. This gives a probability of PB  =  1  −  e−κτ for cells expe-
riencing signalling-induced damage, where κ is a response coefficient and τ is the time for 
which cells are exposed to an above-threshold signal. The level of damage caused is charac-
teristic of the cell-line. Survival is determined from a cumulative damage model. Briefly, both 
direct radiation-induced and indirect signalling-induced damage translate into a number of 
microscopic damage events (“hits”) within each cell, taken to be Poisson distributed around 
mean values determined by dose and the time to which cells are exposed to an above-threshold 
level of signal. This can then potentially lead to cell death either immediately or through 
mitotic catastrophe at the next cell division, with probabilities that depend on the level of dam-
age within each cell. By calculating average damage levels within each voxel, predictions of 
cell damage can thus be made. Further detail can be found in previous publications (Partridge 
2008, McMahon et al 2012).
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In regions which are exposed to modulated fields, signals homogeneously diffuse between 
voxels. This diffusion leads to shifts in the levels of signalling, and thus cell killing, compared 
to uniform irradiations. Signal production and diffusion was modelled in a series of timesteps 
until all cells ceased signalling and the maximum concentration fell below the response 
threshold, allowing for total exposure times to be calculated for each voxel. These were used 
to calculate the probability of signalling-induced damage for cells within each voxel, which in 
turn were used to calculate survival probabilities as outlined above. Input parameters for this 
study were based on those derived for DU-145 prostate cancer cells (McMahon et al 2013a), 
giving LQ parameters of α  =  0.15 and α β = 3 for uniform exposures, as seen experimentally 
(Butterworth et al 2012).
Signal production rates, ν, were estimated as a value of ν  =  0.05ρmax min−1 per voxel, 
where ρmax is the maximum signal concentration. This is sufficient to drive a response if over 
10% of the population has been exposed, as observed experimentally (Butterworth et al 2012). 
While actual in vitro or in vivo signal concentrations are poorly quantified, in this model sur-
vival only depends on the relative values of the maximum signal, production rate and response 
threshold. Thus, all signal concentrations were modelled in units of the maximum concentra-
tion, using a threshold from previous work (McMahon et al 2013a).
Figure 1. (a) Dose distribution through central plane of 20 mm irradiated sphere, 
exposed with a 5 mm margin and d  =  5 mm. (b) Signal concentration around uniformly 
irradiated spheres of different diameters, irradiated with zero margin. Horizontal line 
indicates the response threshold. (c) Signal concentration at the edge of volumes of 
different sizes, exposed with a range of margins. (d) DVHs for a series of target sizes, 
exposed with zero margins. A perfectly conformal delivery of 2 Gy (solid line) leads 
to a variety of different signalling-adjusted dose distributions (dashed lines) depending 
on target size.
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The rate of signal diffusion in vivo remains poorly characterised. Here, diffusion is charac-
terised in terms of the equilibrium range, given by λ=r D/ , where D is the diffusion coef-
ficient. In the examples below, this range is taken as 10 mm, an estimate based on reported 
measurements of in vivo bystander effects (Mancuso et al 2013). In the cases considered here, 
predictions would remain unchanged if both this range and physical dimensions are scaled by 
the same factor.
An analysis of the model’s sensitivity to changes in signal range and production parameters 
is presented in appendix A.
In this analysis, dose delivery is assumed to occur instantaneously, rather than being built up 
over a period of time through multiple fields as is the case in clinical treatment. While a simpli-
fication, experimental evidence suggests that signalling effects are not significantly affected if 
cells are irradiated using a single acute exposure or a longer exposure delivered using techniques 
such as IMRT or VMAT (McGarry et al 2012). Additionally, signal kinetics (McMahon et al 
2013a) suggest that provided the total treatment duration is smaller than the total signal produc-
tion time (on the order of 1 h Gy−1 in DU145 cells), the impact of dose rate would be small.
2.3. Dose Quantification
As the model used in this work predicts a survival level for each individual voxel, ‘signalling-
adjusted’ doses were used for comparisons between model predictions and physical plans 
(McMahon et al 2013b). For a voxel with modelled survival Si, the signalling-adjusted dose 
DS is defined as the dose which would yield the same survival in the limiting case of a large 
uniform exposure, that is =α β− − Se D D i2S S , where α and β are determined from the model’s 
predictions for uniform exposures as noted above.
For comparison between different treatments, CTV Equivalent Uniform Doses (EUDs) 
were calculated, given as =∑α β α β− + − +ve ei D D( EUD EUD ) ( )i i
2 2
, where vi is the fraction of the vol-
ume exposed to the dose Di, where Di can be defined either as the physical dose seen by the 
voxel or the signalling-adjusted dose predicted by the model, to compare between physical 
and model predictions.
2.4. Patient data
An illustrative prostate radiotherapy case was analysed to show these effects in a realistic 
geometry. An initial series of VMAT plans were created with symmetric prostate margins of 
0, 3, 5, 10 or 15 mm with a prescription dose of 8 Gy per fraction over 5 fractions. These plans 
were created using the Eclipse treatment planning system version 11.0.42 (Varian Medical 
Systems, Palo Alto, CA) for delivery on a Varian Truebeam linear accelerator using a single 
arc (30 degree collimator rotation) with a 10 MV flattening filter free (FFF) photon beam of 
dose rate 2400 MU min−1. Plans were normalised so that 98% of the PTV was irradiated to 
98% of the prescription dose. An upper limit of 125% was placed on the PTV and was achieved 
for all margins except for 15 mm. Doses to the urethra, rectum and bladder were minimised as 
much as possible but the priority was placed on coverage of the PTV. The fraction sizes were 
scaled to between 2 and 10 Gy per fraction for fractionation analysis.
2.5. Target displacement
One of the primary motivations for treatment margins is geometric errors. To investi-
gate their impact on signalling, motion was incorporated in a similar fashion to Selvaraj 
(Selvaraj et al 2013).
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Multi-fraction treatment courses were modelled using a Monte Carlo approach. 100 inde-
pendent treatment courses were generated for each dose and margin combination to sample 
possible motion impacts. Within each treatment course, individual fractions were calculated 
independently, with the position of the CTV shifted to represent both systematic uncertain-
ties (a common offset across all fractions in a given treatment course) and random errors (an 
additional, independent shift in each fraction). These errors were generated by sampling 3D 
Gaussian distributions.
The overall impact of motion was quantified by accumulating cell killing across a treatment 
course, assuming no signal persisted between fractions. This was converted into an EUD per 
fraction value for ease of comparison. Repopulation was neglected in this analysis, as it would 
be expected to only provide a constant offset.
3. Results
3.1. Target size and signalling-driven effects
Figure 1(b) illustrates the equilibrium signal concentration for targets of various diameters 
exposed to conformal irradiation with zero margin. Peak concentrations are dependent on 
target size, with significant fall-off at target edges. For very small volumes (<10 mm) the peak 
concentration is below the response threshold, preventing any signalling-induced cell kill-
ing. Figure 1(c) illustrates this, showing the signal concentration at the edge of the CTV. For 
irradiations with no margin, signals do not exceed the response threshold until diameters of at 
least 18 mm. This can lead to significant heterogeneity in cell-killing in these targets, despite 
uniform physical doses. This effect is reduced by adding margins, leading to higher signal 
concentrations and better uniformity across the CTV.
Figure 1(d) presents the signalling-adjusted dose volume histograms (DVHs) for such tar-
gets exposed to uniform doses of 2 Gy. Despite identical physical DVHs, significant varia-
tions occur in modelled cell-killing and thus signalling-adjusted doses. As reported elsewhere 
(McMahon et al 2012), at these doses intercellular communication drives a large portion of 
cell killing, so a dramatic reduction in effect is seen in the smallest targets which experience 
no signalling-driven death. This is mitigated in larger targets due to increasing signalling, 
but even in larger targets there is a degree of heterogeneity (∼5%) and a loss in overall effect 
(∼10%) due to reduced signalling compared to uniform doses.
Figure 2 summarises the potential impact of these signalling-driven effects on the CTV 
EUD following 2 Gy dose delivery to targets of varying sizes and margin prescriptions. For 
the smallest targets (4 mm) there is a reduction equivalent to nearly a 20% under-dosing of 
the target volume due to the lack of signalling-driven effects, although even a 1 mm margin 
significantly abrogated this effect. The scale of this effect reduces gradually with increasing 
target size, with a 5% reduction in EUD for a 5 cm target irradiated with no additional margins.
These results suggest that even where therapy could be delivered without geometric errors, 
there is still a non-trivial benefit of some treatment margin, due to increased cell-killing by 
signalling from non-tumour cells.
3.2. Varying dose per fraction
Due to normal tissue toxicities, margins are particularly significant in hypo-fractionated treat-
ments. However, signalling-driven effects are known to saturate at higher doses (Butterworth 
et al 2011, Butterworth et al 2012), suggesting they may have a reduced importance for larger 
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fractions. Figure 3 presents normalised signalling-adjusted EUDs for varying fraction sizes 
(i.e. signalling-adjusted EUD divided by the physical plan EUD).
While similar trends are seen, the scale of the effect is dramatically reduced at higher 
doses. For zero margin cases, 4 Gy fractions see roughly half the reduction in cell killing at 2 
Gy, with the effect reduced to a few percent at the highest doses. This has the additional effect 
of reducing the sensitivity to margins. While 10 mm margins increased EUDs for 20 mm tar-
gets by roughly 5% at 2 Gy, this is on the order of 1% at 4 Gy.
3.3. Patient Data
Figure 4 presents the impact of these effects in a clinical prostate radiotherapy plan, planned 
with zero CTV margin, and a volume equivalent to a target diameter of 48 mm. When com-
pared to physical dose (top), incorporating signalling-driven effects leads to a significant drop 
in target EUD for 2 Gy fractions (7%, middle), with nearly 20% of the 2 Gy target volume 
now falling below the prescription dose. However, as fraction size is increased this effect 
is diminished, and at 8 Gy fractions little impact is seen (bottom, 1%). These differences 
are highlighted by dose difference plots (right middle & bottom) which show the change in 
Figure 2. Effects of varying target diameter and margin on signalling-adjusted EUD, for 
irradiation of spherical targets to 2 Gy. (a) Effect of varying target diameter for different 
margin prescriptions. (b) Effect of varying margins for different target diameters.
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effective dose between signalling-adjusted and physical doses for high-dose voxels (those 
seeing  >50% of the prescription dose). Outside the target, both fraction sizes see significant 
increases in cell killing in the lower-dose region immediately surrounding the target. More 
detailed discussion of signalling effects in low-dose regions can be found in previous work 
(McMahon et al 2013b).
Signalling-adjusted EUD analysis was carried out for each of these treatment plans, and 
is presented in figure 5, normalised to prescription dose as in figure 3. While comparisons 
between different margin and dosing selections are more difficult due to the increased field 
complexity needed to deliver treatments with the very smallest margins, the key observations 
from the simpler model—that the irradiation of tissue outside the target volume or the use of 
higher doses increases biological effectiveness—remain even in this more complex scenario.
3.4. Tumour motion and fraction size
Figure 6 illustrates the impact of motion in this model. Treatments with an EQD2 of 74 Gy 
were modelled, either as 37  ×  2 Gy fractions, or fewer fractions (illustrated on the upper x 
axis) at higher dose per fraction, for a 20 mm diameter CTV with systematic and random 
uncertainties of 3 mm standard deviation.
Figure 4. Illustration of reduced signalling in clinical external beam radiotherapy plan. 
In this VMAT plan, a given physical dose distribution (top) is converted into signalling-
adjusted dose for doses of 2 (middle) or 8 (bottom) Gy per fraction. Treatments are 
illustrated either as effective dose maps (left) or dose difference maps (right) for voxels 
which see greater than 50% of the prescription dose. A significant drop in target dose 
is seen compared to the physical case at 2 Gy, while good correspondence is seen at 8 
Gy per fraction.
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For physical dose distributions alone (figure 6(a)), these results are comparable to 
previous publications (Selvaraj et al 2013). Geometric uncertainties have a greater 
impact in hypo-fractionated treatments, due to larger risks of geometric miss and sub-
sequent under-dosing. Margins reduce this effect, but the overall trend remains simi-
lar. However, as shown in figure  6(b), signalling effects significantly complicate 
this analysis.
Because the risk of geometric miss now competes with the loss of signalling-driven 
killing, normalised EUD no longer strictly decreases with increasing fraction size. 
Instead, there is a broad maximum at moderate fraction number (5–10, for DU-145 cells), 
which offers a balance between mitigating signalling effects and offsetting the risk of 
geometric miss.
Figure 5. Effects of varying margin and dose per fraction on normalised signalling-
adjusted EUD for a patient geometry. As in the idealised case, increases in both fraction 
size and margin prescription lead to predicted increases in EUD.
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4. Discussion
Radiotherapy optimised according to physical dose is a successful cancer treatment, with 
technological advances driving significant improvements in patient outcome. However, there 
is increasing interest in biological optimisation, incorporating not only geometry but also the 
underlying tumour and normal tissue biology. In this approach, signalling-driven cell killing is 
a complex confounding factor, as it requires an incorporation of spatially-dependent biologi-
cal information rather than the voxel-by-voxel optimisation currently performed.
This study makes several predictions which may impact on planning decisions. One of the 
most important is that cell killing within the target depends, in part, on sufficient signalling 
from irradiation of surrounding normal tissue. While particularly significant for very small 
targets, even in large tumours irradiation of surrounding normal tissue raises the maximum 
signal level and slows its fall-off, leading to increased tumour kill. This suggests that margins 
play both a geometric and biological role, and that these “biological margins” may act as a 
lower bound for conformality, even when geometric uncertainties are minimised.
Larger doses per fraction serve to minimise these effects as they are less dependent on sig-
nalling from outside the target volume to kill cells. However, increases in fraction size must 
be weighed against the risk of geometric miss due to reduced fraction number. As illustrated 
in figure 6(b), this leads to reduced efficacy of both very small and very large fractions, with 
an optimum fraction size for these DU-145 prostate cancer cells between 5 and 8 Gy. These 
fraction sizes have been utilised in several prostate SBRT studies (King et al 2012, Loblaw et 
al 2013).
These effects may contribute to the apparent biological effectiveness of hypo-fractionated 
treatments (Onishi et al 2004, Malmström et al 2012, McBride et al 2012), in two ways. The 
first is by delivering higher EUDs at larger fraction sizes for otherwise identical treatments 
than would be estimated from uniform α β values. The second is the reduced dependence on 
margins in larger fractions, which may contribute to the success of stereotactic treatments with 
very small margins.
Clinical validation of these effects is a challenging prospect. While this model suggests a 
degree of divergence from the traditionally assumed linear-quadratic model, the divergence 
is relatively small (leading to an effective shift on the order of 10% in EUD). This may be 
masked by an apparent reduction in the α β ratio of a similar magnitude, which is significantly 
less than the uncertainty in parameters determined from clinical data (Tree et al 2014).
Some evidence suggests that smaller fractions are more sensitive to margin prescriptions. 
Several groups have reported losses in prostate cancer tumour control with tighter margins 
or more conformal radiotherapy delivery (Engels et al 2009, Heemsbergen et al 2013), sug-
gesting that margins greater than that estimated from geometric parameters may be needed to 
maintain tumour control. By contrast, in hypo-fractionated treatments, extremely small mar-
gins have been successfully used on targets in a variety of sites, despite the expected increase 
in sensitivity to geometric miss. These data, coupled with interest in highly modulated thera-
pies such as dose painting (Bentzen 2005) suggests that there is merit in further investigating 
these effects, as there remains uncertainty about the distribution and causes of recurrence 
following these therapies.
There is also considerable uncertainty in many model parameters. While the sensitivity 
analysis presented in appendix A suggests that overall trends are consistent across a range of 
parameter values, quantitative clinical application will require more robust parameter valida-
tion, as well as an understanding of the effects of communication between different cell types 
and the impact of micro-environmental factors such as hypoxia.
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Notably, the in vivo range of these signals remain uncertain, due to the few studies of highly 
heterogeneous dose distributions in humans or animals. Range quantification is further com-
plicated due to heterogeneous signal diffusion behaviours, both spatially (due to differences 
in vascularisation or boundaries between organs) and temporally (as radiotherapy can have 
significant impacts on vasculature throughout treatment).
The use of small animal radiotherapy platforms (Verhaegen et al 2011) may provide valu-
able insight in this area, through in vivo delivery of both clinically-relevant dose distributions 
and highly heterogeneous doses which could not be delivered clinically but may be relevant to 
probing cellular communication effects.
5. Conclusion
Incorporating intercellular signalling into analysis of margin effects in radiotherapy suggests 
there may be a limit to achievable biological conformality even where geometric uncertainties 
can be eliminated. These effects may be mitigated through the adoption of more biologically 
optimised planning techniques or the use of larger fraction sizes to minimise the contribution 
of signalling effects. Further in vivo data are needed to verify the potential clinical impacts of 
these effects.
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Appendix A.  Sensitivity analysis
While the values chosen for parameters in this work have been informed by in vitro and in vivo 
data, there remains considerable uncertainty, both due to varying cell types and differences 
between experimental and clinical scenarios. To address this, the sensitivity of the model’s 
EUD predictions to variations in signal range, production rate and decay coefficient has been 
assessed. In all cases, 2 Gy physical dose exposures with no margin were modelled, for target 
with diameters of 10 mm, 20 mm and 30 mm. Figure A1 presents the results of varying these 
parameters, with all other parameters fixed at the value given in the main text.
Panels a and b show the impact of signal range. Panel a shows that the EUD falls as a func-
tion of increasing signal range, compared to a large uniform exposure. Greater signal ranges 
imply more rapid signal diffusion, which both decreases the maximum signal for a given 
target of finite size and increases the rate at which signal escapes from the target as cells cease 
signalling. For zero signal ranges, these models return to the same value as local physical 
dose models (the maximum EUD is slightly less than 2 Gy due to physical dose heterogeneity 
across the target). As noted in the main text, the model’s predictions are largely unchanged if 
signal range and physical dimensions are scaled equally. This is illustrated in panel b, which 
shows that the reduction in EUD is approximately equal when the ratio of signal range to 
target diameter is equal.
Panel c shows the dependence of signalling-adjusted EUD on signal production rate. This 
is a relatively simple dependence, where at very low production rates (roughly equal to or less 
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than the decay rate, λ) there is a significant reduction in signalling-adjusted EUD, as signal 
concentrations remain below those which can drive damaging responses. This effect saturates 
rapidly with increasing signal production, and above the 0.05ρmax min−1 rate used in this work, 
little effect is observed as full signalling is seen across the target following radiation exposure.
Panel d shows the more complex dependency on the signal decay coefficient, reflecting the 
interplay between several characteristics. As seen in c, where the decay coefficient is large 
compared to the production rate, cell killing and thus signalling-adjusted EUD fall as the 
maximum signal concentration is reduced by rapid decay, requiring larger irradiated volumes 
to generate an above-threshold response. Indeed, when ν λ ρ< t, decay is sufficient to ensure 
that no signalling-driven effects can be triggered even in a uniformly irradiated volume. For 
lower decay coefficients, a reduction in signalling-adjusted EUD is also seen, as the effect of 
signal diffusion is increased compared to uniform exposures which would not be subject to 
such diffusion. Notably, at extremely low decay coefficients, this trend reverses again, with 
a sharp increase in signalling-adjusted EUD. This effect is driven by signals becoming so 
long-lived that they remain above threshold for extremely long periods, even with diffusion 
of signal throughout the modelled volume. These parameters are relatively balanced across a 
broad maximum in the range 0.01 to 0.05 min−1 (characteristic decay times on the order of 20 
to 100 min), around the experimentally determined decay rate of 0.019 min−1.
Figure A1. Model predictions for signalling-adjusted EUD, based on variation of signal 
range (top), production rate (bottom left) or signal decay (bottom right). Signalling-
adjusted EUD falls with increasing range (a), with a rate which depends on the relative 
length scales of target and range (b). Signalling-adjusted EUD shows a relatively build-
up and saturation with production rate (c). A more complex dependency is seen with 
signal decay (d), which is discussed in the text below. Values of 10 mm, 0.05 min−1 
and 0.019 min−1 were used in the main text for signal range, production rate and decay 
coefficient, respectively.
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While considerable variation in EUD is seen with many of these parameters, the overall 
trends are relatively stable, particularly in the region of the parameters used within this work. 
It should also be noted that many choices of extreme parameter values are not compatible 
with biological knowledge. For example, if decay coefficients were near zero, then very high 
levels of cell killing would be expected even for very low doses, which is not compatible with 
established linear-quadratic responses.
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